StreetAccount Summary: Stocks reaching new 52-week highs/lows (96 total)
StreetAccount Summary - US Initial Syndicate recap for 02-Dec
Belite Bio upgraded to outperform from neutral at Mizuho ($154.02, 0.00)
Belite Bio 2.3M-ADS secondary priced at $154/ADS ($154.02, 0.00)
Belite Bio announces proposed ADS offering of indeterminate amount ($154.02, 0.00)
Powered by FactSet Research Systems Inc.